...
首页> 外文期刊>Stroke: A Journal of Cerebral Circulation >Blood pressure variability on antihypertensive therapy in acute intracerebral hemorrhage: The stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study
【24h】

Blood pressure variability on antihypertensive therapy in acute intracerebral hemorrhage: The stroke acute management with urgent risk-factor assessment and improvement-intracerebral hemorrhage study

机译:急性脑出血的降压治疗中的血压变异性:中风急性发作的紧急危险因素评估和改善性脑出血研究

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND PURPOSE - : The associations between early blood pressure (BP) variability and clinical outcomes in patients with intracerebral hemorrhage after antihypertensive therapy, recently clarified by a post hoc analysis of Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial 2 (INTERACT2), were confirmed using the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement (SAMURAI)-intracerebral hemorrhage study cohort. METHODS - : Patients with hyperacute (<3 hours from onset) intracerebral hemorrhage with initial systolic BP (SBP) >180 mm Hg were registered in a prospective, multicenter, observational study. All patients received antihypertensive therapy based on a predefined standardized protocol to lower and maintain SBP between 120 and 160 mm Hg using intravenous nicardipine. BPs were measured hourly during the initial 24 hours. BP variability was determined as SD and successive variation. The associations between BP variability and hematoma expansion (>33%), neurological deterioration within 72 hours, and unfavorable outcome (modified Rankin Scale, 4-6) at 3 months were assessed. RESULTS - : Of the 205 patients, 33 (16%) showed hematoma expansion, 14 (7%) showed neurological deterioration, and 81 (39%) had unfavorable outcomes. The SD and successive variation of SBP were 13.8 (interquartile range, 11.5-16.8) and 14.9 (11.7-17.7) mm Hg, respectively, and those of diastolic BP were 9.4 (7.5-11.2) and 13.1 (11.2-15.9) mm Hg, respectively. On multivariate regression analyses, neurological deterioration was associated with the SD of SBP (odds ratio, 2.75; 95% confidence interval, 1.45-6.12 per quartile) and the successive variation of SBP (2.37; 1.32-4.83), and unfavorable outcome was associated with successive variation of SBP (1.42; 1.04-1.97). Hematoma expansion was not associated with any BP variability. CONCLUSIONS - : SBP variability during the initial 24 hours of acute intracerebral hemorrhage was independently associated with neurological deterioration and unfavorable outcomes. Stability of antihypertensive therapy may improve clinical outcomes.
机译:背景与目的-:最近通过对急性脑出血试验2中的降压治疗进行了事后分析,明确了降压治疗后脑出血患者的早期血压(BP)变异性与临床结局之间的关联,使用具有紧急危险因素评估和改善(SAMURAI)的脑卒中急性脑卒中患者研究证实。方法-:在前瞻性,多中心,观察性研究中登记了具有超急性(起病时间<3小时)且初始收缩压(SBP)> 180 mm Hg的脑出血的患者。所有患者均接受了基于预定标准化方案的降压治疗,以使用静脉内尼卡地平降低和维持SBP在120至160 mm Hg之间。在最初的24小时内每小时测量一次BP。 BP变异性确定为SD和连续变异。评估了BP变异性与血肿扩大(> 33%),72小时内神经系统恶化以及3个月时不良结局(改良的Rankin评分,4-6)之间的关联。结果-:在205例患者中,有33例(16%)表现为血肿扩大,有14例(7%)表现为神经系统恶化,有81例(39%)的预后不良。 SBP的SD和连续变化分别为13.8(四分位间距,11.5-16.8)和14.9(11.7-17.7)mm Hg,舒张压的SD和连续变化分别为9.4(7.5-11.2)和13.1(11.2-15.9)mm Hg , 分别。在多元回归分析中,神经系统恶化与SBP的SD(赔率,2.75; 95%置信区间,每四分位数1.45-6.12)和SBP的连续变化(2.37; 1.32-4.83)相关,并且不良结果相关与SBP的连续变化(1.42; 1.04-1.97)。血肿扩大与任何BP变异性均不相关。结论-:急性脑出血最初24小时内的SBP变异与神经系统恶化和不良预后独立相关。降压治疗的稳定性可能会改善临床结局。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号